Practice Patterns in Retinopathy of Prematurity Treatment for Disease Milder Than Recommended by Guidelines

Mrinali Patel Gupta, R. V Paul Chan, Rachelle Anzures, Susan Ostmo, Karyn Jonas, Michael Chiang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose To characterize the frequency of and clinical indications for which experts treat retinopathy of prematurity (ROP) milder than type 1 disease, the recommended threshold for treatment from established consensus guidelines. Design Descriptive analysis. Methods setting: Multicenter. study population: A database of 1444 eyes generated prospectively from all babies screened for ROP at 1 of 6 major ROP centers whose parents provided informed consent. intervention: Retrospective review of the database and charts to identify all patients treated for ROP milder than type 1. main outcome measure: Indication(s) for treatment. Results A total of 137 eyes of 70 infants were treated for ROP. Of these 137 eyes, 13 (9.5%) were treated despite a clinical diagnosis milder than type 1 ROP. Indications for treatment included active ROP with the fellow eye being treated for type 1 ROP (2 eyes, 15.4%); concerning structural changes (9 eyes, 69.2%), including tangential traction with temporal vessel straightening concerning for macular dragging (8 eyes, 61.5%) and thick stage 3 membranes with anteroposterior traction concerning for progression to stage 4 ROP (3 eyes, 23.1%); persistent ROP at an advanced postmenstrual age (4 eyes, 30.8%); and/or vitreous hemorrhage (3 eyes, 23.1%). Conclusions Experts in this study occasionally recommended treatment in eyes with disease less than type 1 ROP. This study has important clinical implications and highlights the role of individual clinical judgment in situations not covered by evidence-based treatment guidelines.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalAmerican Journal of Ophthalmology
Volume163
DOIs
StatePublished - Mar 1 2016

Fingerprint

Retinopathy of Prematurity
Guidelines
Therapeutics
Traction
Databases
Vitreous Hemorrhage
Eye Diseases
Informed Consent
Consensus
Parents
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Practice Patterns in Retinopathy of Prematurity Treatment for Disease Milder Than Recommended by Guidelines. / Gupta, Mrinali Patel; Chan, R. V Paul; Anzures, Rachelle; Ostmo, Susan; Jonas, Karyn; Chiang, Michael.

In: American Journal of Ophthalmology, Vol. 163, 01.03.2016, p. 1-10.

Research output: Contribution to journalArticle

Gupta, Mrinali Patel ; Chan, R. V Paul ; Anzures, Rachelle ; Ostmo, Susan ; Jonas, Karyn ; Chiang, Michael. / Practice Patterns in Retinopathy of Prematurity Treatment for Disease Milder Than Recommended by Guidelines. In: American Journal of Ophthalmology. 2016 ; Vol. 163. pp. 1-10.
@article{ba243631e12f4885ae69d8f6e0e03194,
title = "Practice Patterns in Retinopathy of Prematurity Treatment for Disease Milder Than Recommended by Guidelines",
abstract = "Purpose To characterize the frequency of and clinical indications for which experts treat retinopathy of prematurity (ROP) milder than type 1 disease, the recommended threshold for treatment from established consensus guidelines. Design Descriptive analysis. Methods setting: Multicenter. study population: A database of 1444 eyes generated prospectively from all babies screened for ROP at 1 of 6 major ROP centers whose parents provided informed consent. intervention: Retrospective review of the database and charts to identify all patients treated for ROP milder than type 1. main outcome measure: Indication(s) for treatment. Results A total of 137 eyes of 70 infants were treated for ROP. Of these 137 eyes, 13 (9.5{\%}) were treated despite a clinical diagnosis milder than type 1 ROP. Indications for treatment included active ROP with the fellow eye being treated for type 1 ROP (2 eyes, 15.4{\%}); concerning structural changes (9 eyes, 69.2{\%}), including tangential traction with temporal vessel straightening concerning for macular dragging (8 eyes, 61.5{\%}) and thick stage 3 membranes with anteroposterior traction concerning for progression to stage 4 ROP (3 eyes, 23.1{\%}); persistent ROP at an advanced postmenstrual age (4 eyes, 30.8{\%}); and/or vitreous hemorrhage (3 eyes, 23.1{\%}). Conclusions Experts in this study occasionally recommended treatment in eyes with disease less than type 1 ROP. This study has important clinical implications and highlights the role of individual clinical judgment in situations not covered by evidence-based treatment guidelines.",
author = "Gupta, {Mrinali Patel} and Chan, {R. V Paul} and Rachelle Anzures and Susan Ostmo and Karyn Jonas and Michael Chiang",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.ajo.2015.12.005",
language = "English (US)",
volume = "163",
pages = "1--10",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Practice Patterns in Retinopathy of Prematurity Treatment for Disease Milder Than Recommended by Guidelines

AU - Gupta, Mrinali Patel

AU - Chan, R. V Paul

AU - Anzures, Rachelle

AU - Ostmo, Susan

AU - Jonas, Karyn

AU - Chiang, Michael

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Purpose To characterize the frequency of and clinical indications for which experts treat retinopathy of prematurity (ROP) milder than type 1 disease, the recommended threshold for treatment from established consensus guidelines. Design Descriptive analysis. Methods setting: Multicenter. study population: A database of 1444 eyes generated prospectively from all babies screened for ROP at 1 of 6 major ROP centers whose parents provided informed consent. intervention: Retrospective review of the database and charts to identify all patients treated for ROP milder than type 1. main outcome measure: Indication(s) for treatment. Results A total of 137 eyes of 70 infants were treated for ROP. Of these 137 eyes, 13 (9.5%) were treated despite a clinical diagnosis milder than type 1 ROP. Indications for treatment included active ROP with the fellow eye being treated for type 1 ROP (2 eyes, 15.4%); concerning structural changes (9 eyes, 69.2%), including tangential traction with temporal vessel straightening concerning for macular dragging (8 eyes, 61.5%) and thick stage 3 membranes with anteroposterior traction concerning for progression to stage 4 ROP (3 eyes, 23.1%); persistent ROP at an advanced postmenstrual age (4 eyes, 30.8%); and/or vitreous hemorrhage (3 eyes, 23.1%). Conclusions Experts in this study occasionally recommended treatment in eyes with disease less than type 1 ROP. This study has important clinical implications and highlights the role of individual clinical judgment in situations not covered by evidence-based treatment guidelines.

AB - Purpose To characterize the frequency of and clinical indications for which experts treat retinopathy of prematurity (ROP) milder than type 1 disease, the recommended threshold for treatment from established consensus guidelines. Design Descriptive analysis. Methods setting: Multicenter. study population: A database of 1444 eyes generated prospectively from all babies screened for ROP at 1 of 6 major ROP centers whose parents provided informed consent. intervention: Retrospective review of the database and charts to identify all patients treated for ROP milder than type 1. main outcome measure: Indication(s) for treatment. Results A total of 137 eyes of 70 infants were treated for ROP. Of these 137 eyes, 13 (9.5%) were treated despite a clinical diagnosis milder than type 1 ROP. Indications for treatment included active ROP with the fellow eye being treated for type 1 ROP (2 eyes, 15.4%); concerning structural changes (9 eyes, 69.2%), including tangential traction with temporal vessel straightening concerning for macular dragging (8 eyes, 61.5%) and thick stage 3 membranes with anteroposterior traction concerning for progression to stage 4 ROP (3 eyes, 23.1%); persistent ROP at an advanced postmenstrual age (4 eyes, 30.8%); and/or vitreous hemorrhage (3 eyes, 23.1%). Conclusions Experts in this study occasionally recommended treatment in eyes with disease less than type 1 ROP. This study has important clinical implications and highlights the role of individual clinical judgment in situations not covered by evidence-based treatment guidelines.

UR - http://www.scopus.com/inward/record.url?scp=84959328789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959328789&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2015.12.005

DO - 10.1016/j.ajo.2015.12.005

M3 - Article

VL - 163

SP - 1

EP - 10

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

ER -